Sanofi reportedly settles 4K Zantac cases for $100M [Seeking Alpha]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Seeking Alpha
Under the settlement, Sanofi will pay around $25,000 per claim. The suits had alleged that Sanofi failed to adequately warn consumers that one of Zantac's ingredients, ranitidine, could produce the carcinogen NDMA, according to Bloomberg The settlement applies largely to state cases filed outside of Delaware. A Delaware judge is set to decide whether to allow certain scientific evidence underlying the claims for another roughly 70,000 cases. A Florida judge threw out more than 5,000 cases in 2022 citing flawed scientific evidence, Bloomberg added. A Sanofi spokesman told Bloomberg that the company was settling the cases not because it believed the claims had merit, but rather to save the company the expense and distraction of ongoing litigation. Zantac has been marketed by several companies over the years, including Pfizer ( PFE ), GSK ( NYSE: GSK ) and Boehringer Ingelheim. GSK, which developed the drug, has settled similar suits in California, but terms were not disclosed. A
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Global Graft Versus Host Disease (GVHD) Clinical Trials Review 2024 [Yahoo! Finance]Yahoo! Finance
- GSK knew about Zantac cancer risk, attorneys tell jury in first trial [Reuters]Reuters
- GSK knew about Zantac cancer risk, attorneys tell jury in first trial [Yahoo! Finance]Yahoo! Finance
- Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales [Yahoo! Finance]Yahoo! Finance
- E2open Announces Connect Europe 2024 Client Award Winners [Yahoo! Finance]Yahoo! Finance
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 5/2/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- SNY's page on the SEC website